Jeffrey Lieberman, M.D.
Affiliations: | Psychiatry | Columbia University, New York, NY |
Google:
"Jeffrey Lieberman"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Trubetskoy V, Pardiñas AF, Qi T, et al. (2022) Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature |
| Stone WS, Phillips MR, Yang LH, et al. (2022) Neurodegenerative model of schizophrenia: Growing evidence to support a revisit. Schizophrenia Research. 243: 154-162 |
| Zoghbi AW, Dhindsa RS, Goldberg TE, et al. (2021) High-impact rare genetic variants in severe schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 118 |
| Paul SM, Breier A, Lieberman JA, et al. (2021) Clinical Trial of New Drug for Schizophrenia. Reply. The New England Journal of Medicine. 384: e105 |
| Stone WS, Cai B, Liu X, et al. (2020) Association Between the Duration of Untreated Psychosis and Selective Cognitive Performance in Community-Dwelling Individuals With Chronic Untreated Schizophrenia in Rural China. Jama Psychiatry |
| Maes MS, Lu JY, Tiwari AK, et al. (2020) Schizophrenia-associated gene dysbindin-1 and tardive dyskinesia. Drug Development Research |
| Kantrowitz JT, Javitt DC, Freedman R, et al. (2020) Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
| Clelland CL, Kantrowitz JT, Choo T, et al. (2020) Adjunctive sapropterin dihydrochloride treatment in schizophrenia: A positive proof-of-concept, rater-blind, randomized, multivitamin-controlled study. Schizophrenia Research |
| Correll CU, Davis RE, Weingart M, et al. (2020) Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial. Jama Psychiatry |
| Yoshida K, Maciukiewicz M, Marshe V, et al. (2020) M172. POLYGENIC RISK SCORES ANALYSES IN ANTIPSYCHOTIC-INDUCED WEIGHT GAIN Schizophrenia Bulletin. 46: S202-S202 |